24239

    0

    MEDIORG

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    MEDICAMEN ORGANICS LTD Share Price Today

    MEDICAMEN ORGANICS LTD is currently trading at ₹24.7, down by ₹1.29 from the previous close. The stock touched an intraday high of ₹24.70 and a low of ₹24.70 during the latest trading session. Over the past one year, MEDICAMEN ORGANICS LTD has delivered a loss of 40.69%, while the stock has declined 1.2% in the last one month.

    MEDICAMEN ORGANICS LTD performance

    Today’s low Today’s high
    ₹ 24.70 ₹ 24.70
    ₹ 24.70
    52 week low 52 week high
    ₹ 19.10 ₹ 45.00
    ₹ 24.70
    Open Price ₹ 24.70
    Prev. Close ₹ 26.00
    Volume (Shares) 2000.00
    Total traded value ₹ .49
    Upper Circuit ₹ 27.30
    Lower Circuit ₹ 24.70
    info

    Investment Returns

    Over 1 Month -1.20% Over 3 Months -15.41% Over 6 Months 7.15% Over 1 Year -40.69%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    MEDICAMEN ORGANICS LTD fundamentals


    • Market cap (Cr) 30.00
    • P/E Ratio (TTM) -9.88
    • Beta 0.92
    • Book Value / share 23.67
    • Return on equity 14.54%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    MEDICAMEN ORGANICS LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 21.65
    Operating Expense 26.03
    Net Profit -3.05
    Net Profit Margin (%) -14.08
    Earnings Per Share (EPS) -2.58
    EBITDA -2.69
    Effective Tax Rate (%) 29.30
    Particulars MAR 2025 (Values in Cr)
    Revenue 37.09
    Operating Expense 32.79
    Net Profit 3.27
    Net Profit Margin (%) 8.81
    Earnings Per Share (EPS) 2.98
    EBITDA 5.64
    Effective Tax Rate (%) 25.51
    Particulars MAR 2024 (Values in Cr)
    Revenue 25.27
    Operating Expense 21.90
    Net Profit 2.62
    Net Profit Margin (%) 10.36
    Earnings Per Share (EPS) 3.47
    EBITDA 5.81
    Effective Tax Rate (%) 40.76
    Particulars MAR 2023 (Values in Cr)
    Revenue 22.15
    Operating Expense 21.59
    Net Profit 0.97
    Net Profit Margin (%) 4.37
    Earnings Per Share (EPS) 1.60
    EBITDA 2.68
    Effective Tax Rate (%) 28.67
    Particulars MAR 2022 (Values in Cr)
    Revenue 20.98
    Operating Expense 20.93
    Net Profit 0.09
    Net Profit Margin (%) 0.42
    Earnings Per Share (EPS) 0.15
    EBITDA 1.41
    Effective Tax Rate (%) 61.53
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 25.11
    ROE % 17.85
    ROCE % 16.85
    Total Debt to Total Equity 0.55
    EBITDA Margin 17.57
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 17.74
    ROE % 13.11
    ROCE % 14.33
    Total Debt to Total Equity 0.83
    EBITDA Margin 18.84
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 24.76
    ROE % 14.54
    ROCE % 14.04
    Total Debt to Total Equity 0.55
    EBITDA Margin 15.26
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 17.74
    ROE % 16.50
    ROCE % 16.41
    Total Debt to Total Equity 1.01
    EBITDA Margin 18.84
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 14.97
    ROE % 11.73
    ROCE % 10.09
    Total Debt to Total Equity 1.33
    EBITDA Margin 12.10
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 12.60
    ROE % 1.20
    ROCE % 4.08
    Total Debt to Total Equity 1.32
    EBITDA Margin 6.72
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 12.45
    ROE % 4.12
    ROCE % 5.92
    Total Debt to Total Equity 1.23
    EBITDA Margin 6.59
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 4.13
    Total Assets 59.20
    Total Liabilities 59.20
    Total Equity 30.48
    Share Outstanding 1
    Price to Book Ratio 0.88
    Return on Assets (%) 6.83
    Return on Capital (%) 9.45
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.55
    Total Assets 38.44
    Total Liabilities 38.44
    Total Equity 15.25
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 6.82
    Return on Capital (%) 9.4
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 3.26
    Total Assets 57.44
    Total Liabilities 57.44
    Total Equity 29.72
    Share Outstanding 1
    Price to Book Ratio 0.88
    Return on Assets (%) 5.69
    Return on Capital (%) 7.81
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.55
    Total Assets 38.44
    Total Liabilities 38.44
    Total Equity 15.25
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 6.82
    Return on Capital (%) 9.4
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.52
    Total Assets 32.58
    Total Liabilities 32.58
    Total Equity 8.97
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 2.97
    Return on Capital (%) 4.67
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.43
    Total Assets 27.07
    Total Liabilities 27.07
    Total Equity 7.55
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 0.34
    Return on Capital (%) 0.52
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.88
    Total Assets 26.34
    Total Liabilities 26.34
    Total Equity 7.46
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 1.13
    Return on Capital (%) 1.75
    Particulars MAR 2025 (Values in Cr)
    Net Income 5.43
    Cash from Operations -4.44
    Cash from Investing -2.35
    Cash from Financing 10.47
    Net change in Cash 3.57
    Free Cash Flow -2.00
    Particulars MAR 2024 (Values in Cr)
    Net Income 3.38
    Cash from Operations -3.48
    Cash from Investing -0.33
    Cash from Financing 4.01
    Net change in Cash 0.01
    Free Cash Flow -3.13
    Particulars MAR 2025 (Values in Cr)
    Net Income 4.38
    Cash from Operations -4.81
    Cash from Investing -2.62
    Cash from Financing 10.25
    Net change in Cash 2.71
    Free Cash Flow -2.36
    Particulars MAR 2024 (Values in Cr)
    Net Income 3.38
    Cash from Operations -3.48
    Cash from Investing -0.33
    Cash from Financing 4.01
    Net change in Cash 0.01
    Free Cash Flow -3.13
    Particulars MAR 2023 (Values in Cr)
    Net Income 1.35
    Cash from Operations -0.53
    Cash from Investing -0.28
    Cash from Financing 0.93
    Net change in Cash 0.07
    Free Cash Flow -0.24
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.25
    Cash from Operations 0.10
    Cash from Investing -0.59
    Cash from Financing 0.18
    Net change in Cash -0.37
    Free Cash Flow 0.71
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.49
    Cash from Operations -1.11
    Cash from Investing -0.01
    Cash from Financing 1.26
    Net change in Cash 0.09
    Free Cash Flow -1.09
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 32.45 13.46 1.57 248.68 23.12 38.85
    BLISS GVS PHARMA LTD 463.55 37.26 4.12 4916.24 118.35 552.90
    CIPLA LTD. 1410.90 31.85 3.31 113978.90 1165.55 1672.20
    FERMENTA BIOTECH LTD. 432.60 20.23 3.13 1273.18 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 32.45 22.69 4.18 248.68 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 510.50 22.88 3.98 1475.89 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8000.10 104.55 22.91 20000.25 7630.00 9850.00
    BLISS GVS PHARMA LTD 463.55 50.11 4.25 4916.24 118.35 552.90

    MEDICAMEN ORGANICS LTD shareholding pattern

    Holding
    45.05%
    54.89%
    0.05%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    MEDICAMEN ORGANICS LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    24.70 -5.00 redarrow
    red-green-graph indicator
    4 Bearish
    12 Bullish
    • 5 Days 24.60
    • 26 Days 23.80
    • 10 Days 24.20
    • 50 Days 24.00
    • 12 Days 24.10
    • 100 Days 24.80
    • 20 Days 23.80
    • 200 Days 28.70
    25.67 PIVOT
    First Support 25.33 First Resistance 26.33 Second Support 24.67 Second Resistance 26.67 Third Support 24.33 Third Resistance 27.33
    RSI 54.58 ADX 14.47 MACD 0.29 Williams % R -33.33 Commodity Channel Index (CCI) 52.11
    Date 2026-07-24 Week 26800.00 Same Day 2000.00 Month 15333.00
    1 Year 0.92 3 Year 0.67
    Over 1 Month
    -1.20% down
    Over 1 Year
    -40.69% down
    Over 3 Months
    -15.41% down
    Over 3 Years
    -44.52% down
    Over 6 Months
    7.15% down
    Over 5 Years
    0.00% down

    MEDICAMEN ORGANICS LTD Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Medicamen Organics Ltd?

    Answer Field

    Medicamen Organics Ltd share price is for NSE ₹ 24.70 & for BSE ₹ 0.00 as on Jul 24 2026 03:10 PM.

    What is the Market Cap of Medicamen Organics Ltd Share?

    Answer Field

    The market cap of Medicamen Organics Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 24 2026 03:10 PM.

    What is the 52 Week High and Low of Medicamen Organics Ltd?

    Answer Field

    The 52 Week High and Low of Medicamen Organics Ltd for NSE is ₹ 45.00 and ₹ 19.10 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Medicamen Organics Ltd?

    Answer Field

    The 1 year returns on the stock has been -40.69%.

    What is the P/E Ratio of Medicamen Organics Ltd Share?

    Answer Field

    As on Jul 24 2026 03:10 PM the price-to-earnings (PE) ratio for Medicamen Organics Ltd share is -9.88.

    What is the PB ratio of Medicamen Organics Ltd Share?

    Answer Field

    As on Jul 24 2026 03:10 PM, the price-to-book (PB) ratio for Medicamen Organics Ltd share is 23.67.

    How to Buy Medicamen Organics Ltd Share?

    Answer Field

    You can trade in Medicamen Organics Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Medicamen Organics Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Medicamen Organics Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Medicamen Organics Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |